Related Experiment Videos
[Furacilin compound cream for profound frostbite]
1Tianjin Second Medical College.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|November 1, 1993
Summary
Furacilin compound cream significantly improved frostbite tissue survival in animal studies, increasing the survival rate from 12% to 62%. Clinical trials also showed satisfactory results in patients with profound frostbite.
Area of Science:
- Biomedical research
- Wound healing
- Dermatology
Background:
- Profound frostbite presents a significant clinical challenge with high rates of tissue necrosis.
- Current treatments for severe frostbite have limited efficacy in preventing tissue loss.
- Understanding mechanisms to reduce vascular permeability is crucial for frostbite management.
Observation:
- An animal model was used to investigate the efficacy of Furacilin compound cream in treating frostbite.
- Vascular permeability in frostbite tissue was assessed.
- Tissue survival rates were compared between a control group and a group treated with Furacilin cream.
Findings:
- Furacilin compound cream demonstrated a significant reduction in vascular permeability in frostbite tissue.
- The average survival rate of frostbite tissue increased from 12.0% +/- 1.2% in the control group to 62.0% +/- 3.7% in the Furacilin-treated group.
- This difference was statistically significant (P < 0.001).
Implications:
- Furacilin compound cream shows promise as a therapeutic agent for profound frostbite.
- The cream's ability to reduce vascular permeability may be key to its protective effects.
- Further clinical investigation is warranted to confirm these findings in human patients.